Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
Authors
Keywords
-
Journal
Gastric Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-26
DOI
10.1007/s10120-021-01160-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015
- (2020) Rosa T. van der Kaaij et al. EUROPEAN JOURNAL OF CANCER
- Clinical and pathological staging of gastric cancer: Current perspectives and implications
- (2020) Zhi Zhu et al. EJSO
- Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
- (2020) Olivia Sgarbura et al. EJSO
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)
- (2019) Israel Manzanedo et al. ANNALS OF SURGICAL ONCOLOGY
- Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
- (2019) W. J. Koemans et al. BMC CANCER
- Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
- (2019) Pierre-Emmanuel Bonnot et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Peritoneal metastasis in gastric cancer: results from the German database
- (2019) Beate Rau et al. Gastric Cancer
- Heterogeneity of first‐line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real‐world evidence study
- (2019) Willemieke P.M. Dijksterhuis et al. INTERNATIONAL JOURNAL OF CANCER
- Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma
- (2018) Jun H. Lee et al. ANNALS OF SURGERY
- Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden
- (2018) Johannes Asplund et al. ANNALS OF SURGICAL ONCOLOGY
- Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)
- (2018) H. J. F. Brenkman et al. BMC CANCER
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET ONCOLOGY
- The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
- (2017) Jacopo Desiderio et al. EUROPEAN JOURNAL OF CANCER
- Prognostic factors in patients with loco-regionally advanced gastric cancer
- (2017) Bo Hultman et al. World Journal of Surgical Oncology
- Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
- (2017) Charles S. Fuchs et al. Journal of Gastric Cancer
- Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis
- (2016) Andrea Laghi et al. Radiologia Medica
- Metastatic spread in patients with gastric cancer
- (2016) Matias Riihimäki et al. Oncotarget
- Comparison of MRI and CT for Predicting the Peritoneal Cancer Index (PCI) Preoperatively in Patients Being Considered for Cytoreductive Surgical Procedures
- (2014) Russell N. Low et al. ANNALS OF SURGICAL ONCOLOGY
- Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution
- (2014) Dong Hoe Koo et al. Gastric Cancer
- Prognostic Role of Gastrectomy in Patients With Gastric Cancer With Positive Peritoneal Cytology
- (2014) Okihide Suzuki et al. INTERNATIONAL SURGERY
- Chemotherapy as palliative treatment for peritoneal carcinomatosis of gastric origin
- (2013) Irene Thomassen et al. ACTA ONCOLOGICA
- Gastric cancer: Decreasing incidence but stable survival in the Netherlands
- (2013) Anneriet E. Dassen et al. ACTA ONCOLOGICA
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer
- (2008) Vic J. Verwaal et al. ANNALS OF SURGICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started